Talks will cover the use of a novel BBB-penetrant, AAV5-derived CNS capsid and development of an RNA-targeting disease-modifying gene therapy,…
MMJ BioPharma Cultivation is completing its Cannabis DEA bulk manufacturing license process, a seven-year DEA battle that has delayed the…
Partnership equips Brain Balance to scale its national network with a unified EHR that integrates clinical, financial, and operational workflows,…
The addition of cardiology and neurology experts helps health companies scale evidence-based health products with confidence AUSTIN, Texas, Sept. 25,…
Immersive AI Education & Experience for Home Care and Senior Living Leaders Not Yet Using Sensi PALO ALTO, Calif., Sept.…
MINNEAPOLIS, Sept. 25, 2025 /PRNewswire/ -- The National Ataxia Foundation (NAF) today announced the launch of The Science Guy: Back in…
Company strategy: In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia for treatment…
HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company…
HOUSTON, TX, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader…
Late-breaking clinical data presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis Across non-active…